MannKind Corp. (MNKD)

[TREND1]

Important part of your article was a comment
Hung Tran

Mr. Silverman's article is superbly written, as the author presents a well-balanced narrative on the dilemma facing Sanofi. In following some key points elucidated by Mr. Silverman, I support a long thesis that the Afrezza-Toujeo combinations will highly likely to exceed Lantus' peak sales of $8 billion based of the science and medicine, as well as marketing factors. You can access the MD-360 Research article by followingthe link, https://www.retailinvestor360.com/biotech/671-sanofi-is-in-turmoil-will-afrezza-and-toujeo-combinations-save-lantus.html

the above is ,.....
Sanofi is in Turmoil: Will Afrezza and Toujeo Combinations Save Lantus?